US2956062A
(en)
|
1959-02-26 |
1960-10-11 |
Robins Co Inc A H |
Esters of amino alcohols
|
US3175299A
(en)
*
|
1961-08-02 |
1965-03-30 |
American Sugar |
Method of drying sugar crystals with acoustic energy and a gas
|
US3994974A
(en)
|
1972-02-05 |
1976-11-30 |
Yamanouchi Pharmaceutical Co., Ltd. |
α-Aminomethylbenzyl alcohol derivatives
|
SE378109B
(zh)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
US4187301A
(en)
|
1978-04-05 |
1980-02-05 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 6 alpha, 6 beta-difluoro-3-oxoandrost-4-enes
|
JPS56138200A
(en)
|
1980-02-15 |
1981-10-28 |
Glaxo Group Ltd |
Androstane carbothioate compound
|
ATE8790T1
(de)
|
1981-02-02 |
1984-08-15 |
Schering Corporation |
Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
|
EP0072046B1
(en)
*
|
1981-07-24 |
1986-01-15 |
FISONS plc |
Inhalation drugs, methods for their production and pharmaceutical formulations containing them
|
ZW6584A1
(en)
|
1983-04-18 |
1985-04-17 |
Glaxo Group Ltd |
Phenethanolamine derivatives
|
GB8432063D0
(en)
|
1984-12-19 |
1985-01-30 |
Riker Laboratories Inc |
Physically modified steroids
|
US5707634A
(en)
|
1988-10-05 |
1998-01-13 |
Pharmacia & Upjohn Company |
Finely divided solid crystalline powders via precipitation into an anti-solvent
|
GB8903593D0
(en)
|
1989-02-16 |
1989-04-05 |
Pafra Ltd |
Storage of materials
|
IL95590A
(en)
|
1989-09-08 |
1996-06-18 |
Glaxo Group Ltd |
Medicinal preparations containing Salmetrol and Pluticasone Propionate
|
JP3042866B2
(ja)
|
1989-09-08 |
2000-05-22 |
グラクソ・グループ・リミテッド |
呼吸疾患治療薬
|
DE3931041C2
(de)
|
1989-09-16 |
2000-04-06 |
Boehringer Ingelheim Kg |
Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
|
US5610163A
(en)
|
1989-09-16 |
1997-03-11 |
Boehringer Ingelheim Gmbh |
Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
|
SG45171A1
(en)
|
1990-03-21 |
1998-01-16 |
Boehringer Ingelheim Int |
Atomising devices and methods
|
ES2065701T3
(es)
|
1990-09-10 |
1995-02-16 |
Schering Corp |
Furoato de mometasona monohidrato, procedimiento para fabricar el mismo y composiciones farmaceuticas.
|
DE4108393A1
(de)
|
1991-03-15 |
1992-09-17 |
Boehringer Ingelheim Kg |
Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
|
US5874063A
(en)
|
1991-04-11 |
1999-02-23 |
Astra Aktiebolag |
Pharmaceutical formulation
|
SE9302777D0
(sv)
*
|
1993-08-27 |
1993-08-27 |
Astra Ab |
Process for conditioning substances
|
SE9101090D0
(sv)
|
1991-04-11 |
1991-04-11 |
Astra Ab |
Process for conditioning of water-soluble substances
|
AU659645B2
(en)
|
1991-06-26 |
1995-05-25 |
Inhale Therapeutic Systems |
Storage of materials
|
ATE213946T1
(de)
|
1991-12-18 |
2002-03-15 |
|
Formoterol und budesonide enthaltende zusammensetzung
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US5849263A
(en)
|
1993-03-30 |
1998-12-15 |
Charlotte-Mecklenburg Hospital Authority |
Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
|
GB9313642D0
(en)
|
1993-07-01 |
1993-08-18 |
Glaxo Group Ltd |
Method and apparatus for the formation of particles
|
WO1995015151A1
(en)
|
1993-12-02 |
1995-06-08 |
Abbott Laboratories |
Aerosol drug formulations for use with non-cfc propellants
|
SE9404080L
(sv)
|
1993-12-28 |
1995-06-29 |
Ciba Geigy Ag |
Förfarande för framställning av en optiskt ren enantiomer av formoterol
|
US5837699A
(en)
|
1994-01-27 |
1998-11-17 |
Schering Corporation |
Use of mometasone furoate for treating upper airway passage diseases
|
AU680727B2
(en)
|
1994-02-09 |
1997-08-07 |
Kinerton Limited |
Process for drying a material from solution
|
GB9413202D0
(en)
|
1994-06-30 |
1994-08-24 |
Univ Bradford |
Method and apparatus for the formation of particles
|
DE4440337A1
(de)
|
1994-11-11 |
1996-05-15 |
Dds Drug Delivery Services Ges |
Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
|
MX9704550A
(es)
|
1994-12-22 |
1997-10-31 |
Astra Ab |
Formulaciones de medicamentos en aerosol.
|
US5612053A
(en)
|
1995-04-07 |
1997-03-18 |
Edward Mendell Co., Inc. |
Controlled release insufflation carrier for medicaments
|
GB9507768D0
(en)
|
1995-04-13 |
1995-05-31 |
Glaxo Group Ltd |
Method of apparatus
|
US6309671B1
(en)
|
1995-04-14 |
2001-10-30 |
Inhale Therapeutic Systems |
Stable glassy state powder formulations
|
US6258341B1
(en)
|
1995-04-14 |
2001-07-10 |
Inhale Therapeutic Systems, Inc. |
Stable glassy state powder formulations
|
JP3708553B2
(ja)
|
1995-04-14 |
2005-10-19 |
ネクター セラピューティクス |
向上した分散性を有する粉末型薬理組成物
|
US5833891A
(en)
|
1996-10-09 |
1998-11-10 |
The University Of Kansas |
Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
|
DE19614421C2
(de)
|
1996-04-12 |
1999-12-16 |
Biovision Gmbh |
Verfahren zur Herstellung eines biodegradierbaren Knochenersatz- und Implantatwerkstoffes und biodegradierbarer Knochenersatz- und Implantatwerkstoff
|
GB9610821D0
(en)
|
1996-05-23 |
1996-07-31 |
Glaxo Wellcome Inc |
Metering apparatus
|
GB9612297D0
(en)
|
1996-06-11 |
1996-08-14 |
Minnesota Mining & Mfg |
Medicinal aerosol formulations
|
US6054488A
(en)
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
US5886200A
(en)
|
1996-07-01 |
1999-03-23 |
Schering Corporation |
Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
|
US6068832A
(en)
|
1996-08-29 |
2000-05-30 |
Schering Corporation |
Chlorofluorocarbon-free mometasone furoate aerosol formulations
|
US6040344A
(en)
|
1996-11-11 |
2000-03-21 |
Sepracor Inc. |
Formoterol process
|
SE9700135D0
(sv)
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
CN1149076C
(zh)
|
1997-03-20 |
2004-05-12 |
先灵公司 |
粉末附聚物的制备方法
|
US6129905A
(en)
|
1997-04-21 |
2000-10-10 |
Aeropharm Technology, Inc. |
Aerosol formulations containing a sugar as a dispersant
|
US6010935A
(en)
|
1997-08-21 |
2000-01-04 |
Micron Technology, Inc. |
Self aligned contacts
|
SE9703407D0
(sv)
|
1997-09-19 |
1997-09-19 |
Astra Ab |
New use
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6946117B1
(en)
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
US6433040B1
(en)
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
DE69814428T2
(de)
|
1997-09-29 |
2004-05-13 |
Nektar Therapeutics, San Carlos |
In verneblern verwendbare, stabilisierte zubereitungen
|
GB9808470D0
(en)
|
1998-04-22 |
1998-06-17 |
Smithkline Beecham Plc |
Novel process and apparatus
|
US6260549B1
(en)
|
1998-06-18 |
2001-07-17 |
Clavius Devices, Inc. |
Breath-activated metered-dose inhaler
|
US6451285B2
(en)
|
1998-06-19 |
2002-09-17 |
Baker Norton Pharmaceuticals, Inc. |
Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
|
EP1102579B1
(de)
|
1998-08-04 |
2003-03-19 |
Jago Research Ag |
Medizinische aerosolformulierungen
|
PT1283036E
(pt)
|
1998-11-13 |
2008-03-06 |
Jagotec Ag |
Inalador de pó seco de dose múltipla com um reservatório de pó
|
GB9912639D0
(en)
|
1999-05-28 |
1999-07-28 |
Britannia Pharmaceuticals Ltd |
Improvements in and relating to treatment of respiratory conditions
|
GB9826284D0
(en)
*
|
1998-12-01 |
1999-01-20 |
Rhone Poulence Rorer Limited |
Process
|
WO2000036915A1
(en)
|
1998-12-22 |
2000-06-29 |
The University Of North Carolina At Chapel Hill |
Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
|
GB9902689D0
(en)
|
1999-02-08 |
1999-03-31 |
Novartis Ag |
Organic compounds
|
GB9903759D0
(en)
|
1999-02-18 |
1999-04-14 |
Novartis Ag |
Organic compounds
|
GB9904919D0
(en)
|
1999-03-03 |
1999-04-28 |
Novartis Ag |
Organic compounds
|
TR200102567T2
(tr)
|
1999-03-05 |
2002-01-21 |
Chiesi Farmaceutici S.P.A. |
İnhalasyon için geliştirilmiş toz halindeki farmasötik bileşimler
|
SE9900833D0
(sv)
|
1999-03-09 |
1999-03-09 |
Astra Ab |
Novel combination
|
DE19921693A1
(de)
|
1999-05-12 |
2000-11-16 |
Boehringer Ingelheim Pharma |
Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
|
ATE233084T1
(de)
|
1999-04-14 |
2003-03-15 |
Glaxo Group Ltd |
Pharmazeutische aerosolformulierung
|
US20100197719A1
(en)
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US6255320B1
(en)
*
|
1999-06-01 |
2001-07-03 |
Pfizer Inc. |
Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
|
ATE263767T1
(de)
*
|
1999-06-03 |
2004-04-15 |
Eisai Co Ltd |
Kristalline cabapenemderivate und pharmazeutische zubereitungen zur injektion
|
AU780327B2
(en)
|
1999-06-30 |
2005-03-17 |
Novartis Ag |
Spray drying process for preparing dry powders
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
NZ500555A
(en)
|
1999-08-02 |
2000-11-24 |
Hovione Int Ltd |
Process for the preparation of mometasone furoate
|
US6586008B1
(en)
|
1999-08-25 |
2003-07-01 |
Advanced Inhalation Research, Inc. |
Use of simple amino acids to form porous particles during spray drying
|
MXPA02004193A
(es)
|
1999-10-29 |
2002-12-13 |
Inhale Therapeutic Syst |
Composiciones de polvo seco que tienen caracteristicas de dispersion mejoradas.
|
US6596261B1
(en)
|
2000-01-25 |
2003-07-22 |
Aeropharm Technology Incorporated |
Method of administering a medicinal aerosol formulation
|
IT1317846B1
(it)
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
GB0008660D0
(en)
|
2000-04-07 |
2000-05-31 |
Arakis Ltd |
The treatment of respiratory diseases
|
TWI290473B
(en)
|
2000-05-10 |
2007-12-01 |
Alliance Pharma |
Phospholipid-based powders for drug delivery
|
US20060257324A1
(en)
|
2000-05-22 |
2006-11-16 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical solution formulations for pressurised metered dose inhalers
|
US20040081627A1
(en)
|
2000-10-09 |
2004-04-29 |
Jinks Phillip A |
Medicinal aerosol formulations
|
US6908928B2
(en)
|
2000-10-12 |
2005-06-21 |
Bi Pharma Kg. |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
|
PT1920763E
(pt)
|
2000-11-30 |
2014-06-25 |
Vectura Ltd |
Composições farmacêuticas para inalação
|
GB0030074D0
(en)
*
|
2000-12-08 |
2001-01-24 |
Univ London Pharmacy |
Particulate inhalation carrier
|
US20020141946A1
(en)
|
2000-12-29 |
2002-10-03 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
ITMI20010428A1
(it)
|
2001-03-02 |
2002-09-02 |
Chemo Breath S A |
Composizioni ad uso inalatorio a base di formoterolo
|
BR0208012A
(pt)
|
2001-03-20 |
2004-03-02 |
Glaxo Group Ltd |
Usos de pelo menos duas drogas e um propelente hfa e de pelo menos uma composição farmaceêutica, e, inalador acondicionado para tratar asma
|
ATE375142T1
(de)
|
2001-03-30 |
2007-10-15 |
Jagotec Ag |
Medizinische aerosolformulierungen
|
US6667344B2
(en)
|
2001-04-17 |
2003-12-23 |
Dey, L.P. |
Bronchodilating compositions and methods
|
US6848197B2
(en)
|
2001-04-18 |
2005-02-01 |
Advanced Inhalation Research, Inc. |
Control of process humidity to produce large, porous particles
|
DE10120484A1
(de)
*
|
2001-04-25 |
2002-10-31 |
Degussa |
Verfahren und Vorrichtung zur thermischen Behandlung von pulverförmigen Stoffen
|
DE10130371A1
(de)
|
2001-06-23 |
2003-01-02 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
|
US20030018019A1
(en)
|
2001-06-23 |
2003-01-23 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
|
AR036358A1
(es)
|
2001-08-28 |
2004-09-01 |
Schering Corp |
Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
|
DE10202940A1
(de)
|
2002-01-24 |
2003-07-31 |
Sofotec Gmbh & Co Kg |
Patrone für einen Pulverinhalator
|
JP2006512044A
(ja)
|
2002-03-07 |
2006-04-13 |
アバロン ファーマシューティカルズ,インコーポレイテッド |
化学療法のための標的としての癌関連遺伝子
|
DE10214264A1
(de)
|
2002-03-28 |
2003-10-16 |
Boehringer Ingelheim Pharma |
HFA-Suspensionsformulierungen eines Anhydrats
|
GB0207906D0
(en)
|
2002-04-05 |
2002-05-15 |
3M Innovative Properties Co |
Formoterol and mometasone aerosol formulations
|
DE10216429A1
(de)
|
2002-04-12 |
2003-10-23 |
Boehringer Ingelheim Pharma |
Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
|
CN1674918A
(zh)
|
2002-06-12 |
2005-09-28 |
埃匹吉尼斯医药有限公司 |
利用脱氢表雄酮甾体及抗毒蕈碱药物治疗呼吸道疾病及肺病的组合物、制剂和试剂盒
|
DE10237739A1
(de)
|
2002-08-17 |
2004-02-26 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
|
US7244742B2
(en)
|
2002-08-17 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
|
CA2499099C
(en)
|
2002-10-15 |
2009-01-20 |
Cryovac, Inc. |
A process for triggering, storing, and distributing an oxygen scavenger, and a stored oxygen scavenger
|
US20040121003A1
(en)
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
DE10323966A1
(de)
|
2003-05-27 |
2004-12-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue langwirksame Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
|
KR20060015316A
(ko)
|
2003-05-28 |
2006-02-16 |
넥타르 테라퓨틱스 |
아미노산 및/또는 인지질로 부분 또는 완전 코팅된수불용성 활성제 미립자의 제조를 위한 알코올성 수용액의분무 건조법
|
WO2004110450A1
(en)
|
2003-06-16 |
2004-12-23 |
Altana Pharma Ag |
Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases
|
SE527190C2
(sv)
|
2003-06-19 |
2006-01-17 |
Microdrug Ag |
Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid
|
WO2005013992A1
(en)
|
2003-07-28 |
2005-02-17 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising betamimetics and an anticholinergic agent
|
BRPI0413054A
(pt)
|
2003-07-29 |
2006-10-17 |
Boehringer Ingelheim Int |
combinação de um anticolinérgico e um esteróide e seu uso no tratamento de distúrbios respiratórios por inalação
|
PL1651270T3
(pl)
|
2003-07-29 |
2007-06-29 |
Boehringer Ingelheim Int |
Leki do inhalacji zawierające betamimetyki i środki przeciwcholinergiczne
|
EP1651224B1
(en)
|
2003-07-31 |
2011-10-05 |
Boehringer Ingelheim International GmbH |
Medicaments for inhalation comprising an anticholinergic and a betamimetic
|
US9308199B2
(en)
|
2004-04-29 |
2016-04-12 |
Honeywell International Inc. |
Medicament formulations
|
SE0303270L
(sv)
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Metod för administration av tiotropium
|
PL1713473T3
(pl)
|
2004-02-06 |
2013-08-30 |
Meda Pharma Gmbh & Co Kg |
Kombinacja leków antycholinergicznych i glikokortykoidów do długotrwałego leczenia astmy i POChP
|
EP1718336B1
(en)
|
2004-02-06 |
2008-06-25 |
MEDA Pharma GmbH & Co. KG |
Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases
|
US20050287077A1
(en)
|
2004-02-10 |
2005-12-29 |
James E. Shipley |
Process for preparing stable SOL of pharmaceutical ingredients and hydrofluorocarbon
|
GB0409703D0
(en)
†
|
2004-04-30 |
2004-06-02 |
Vectura Ltd |
Pharmaceutical compositions
|
GB0411056D0
(en)
|
2004-05-18 |
2004-06-23 |
Novartis Ag |
Organic compounds
|
WO2005115520A1
(en)
*
|
2004-05-20 |
2005-12-08 |
Discovery Laboratories, Inc. |
Methods , systems and devices for noninvasive pulmonary delivery
|
SI1765288T1
(sl)
|
2004-06-18 |
2013-02-28 |
Novartis Ag |
Formulacije tobramicina za zdravljenje endobronhialnih infekcij
|
GB0426301D0
(en)
|
2004-11-30 |
2004-12-29 |
Vectura Ltd |
Pharmaceutical formulations
|
US7915303B2
(en)
|
2005-03-24 |
2011-03-29 |
Sosei R&D Ltd. |
Glycopyrronium salts and their therapeutic use
|
JP2008534611A
(ja)
|
2005-03-30 |
2008-08-28 |
シェーリング コーポレイション |
抗コリン作用薬、コルチコステロイドおよび長時間作用性βアゴニストを合わせる薬物および方法
|
CA2607391A1
(en)
|
2005-04-23 |
2006-11-02 |
Boehringer Ingelheim International Gmbh |
Combination of medicaments to be inhaled, containing a betamimetic agent and a steroid in addition to an anticholinergic agent
|
GB0523653D0
(en)
|
2005-11-21 |
2005-12-28 |
Novartis Ag |
Organic compounds
|
JP2008542332A
(ja)
|
2005-05-31 |
2008-11-27 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
呼吸器疾患治療用新規医薬組成物
|
EP1904219A4
(en)
|
2005-07-15 |
2011-07-27 |
Map Pharmaceuticals Inc |
METHOD FOR FORMING PARTICLES
|
CN100560598C
(zh)
|
2005-07-26 |
2009-11-18 |
上海奥锐特国际贸易有限公司 |
氟替卡松丙酸酯的合成方法
|
GB0523656D0
(en)
|
2005-11-21 |
2005-12-28 |
Novartis Ag |
Organic compounds
|
GB0523654D0
(en)
|
2005-11-21 |
2005-12-28 |
Novartis Ag |
Organic compounds
|
GB0523655D0
(en)
|
2005-11-21 |
2005-12-28 |
Novartis Ag |
Organic compounds
|
WO2007071313A2
(en)
|
2005-12-21 |
2007-06-28 |
Meda Pharma Gmbh & Co Kg |
Combination of anticholinergics, glucocorticoids, beta2-ag0nists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases
|
US8263645B2
(en)
|
2006-02-03 |
2012-09-11 |
Pari Pharma Gmbh |
Disodium cromoglycate compositions and methods for administering same
|
EP1981475A2
(en)
|
2006-02-09 |
2008-10-22 |
Schering Corporation |
Pharmaceutical formulations
|
US20110135580A1
(en)
|
2006-05-24 |
2011-06-09 |
Boehringer Ingelheim International Gmbh |
Novel Medicament Combinations for the Treatment of Respiratory Diseases
|
GB0613161D0
(en)
|
2006-06-30 |
2006-08-09 |
Novartis Ag |
Organic Compounds
|
GB0614621D0
(en)
|
2006-07-24 |
2006-08-30 |
3M Innovative Properties Co |
Metered dose dispensers
|
EP1894568A1
(en)
|
2006-08-31 |
2008-03-05 |
Novartis AG |
Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases
|
EP2327403A3
(en)
|
2007-02-19 |
2011-08-31 |
Cipla Limited |
Pharmaceutical combinations of at least two bronchodilators
|
EP2036572A1
(en)
|
2007-09-04 |
2009-03-18 |
Novo Nordisk A/S |
Process for drying a protein, a protein particle and a pharmaceutical composition comprising the protein particle
|
GB0801876D0
(en)
|
2008-02-01 |
2008-03-12 |
Vectura Group Plc |
Suspension formulations
|
FR2940162B1
(fr)
|
2008-12-22 |
2011-02-25 |
Boehm & Cie Ets |
Outil de frappe multi-usages a mecanisme absorbant l'energie transmise au moyen de prehension
|
WO2010097188A1
(en)
|
2009-02-25 |
2010-09-02 |
Chiesi Farmaceutici S.P.A. |
Inhalation particles comprising a salt of carmoterol and a corticosteroid
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
PL3111926T3
(pl)
|
2009-05-29 |
2020-06-29 |
Pearl Therapeutics, Inc. |
Kompozycje, sposoby i układy do dostarczania dwóch lub większej liczby środków czynnych do układu oddechowego
|
EP2627317A4
(en)
*
|
2010-10-15 |
2014-08-20 |
Glaxo Group Ltd |
MEDICINAL FORMULATIONS FROM AGGREGATED NANOPARTICLES AND THEIR PREPARATION AND USE
|
EP2749284A3
(en)
|
2011-02-17 |
2014-08-20 |
Cipla Limited |
Combination of glycopyrronium and carmoterol
|
JO3510B1
(ar)
*
|
2011-03-04 |
2020-07-05 |
Heptares Therapeutics Ltd |
استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
|
KR20140032404A
(ko)
|
2011-05-17 |
2014-03-14 |
펄 테라퓨틱스 인코포레이티드 |
2 개 이상의 활성제의 호흡기 전달을 위한 조성물, 방법 & 시스템
|
US20120325942A1
(en)
|
2011-06-27 |
2012-12-27 |
General Electric Company |
Jet milling of boron powder using inert gases to meet purity requirements
|
US20140275517A1
(en)
|
2013-03-15 |
2014-09-18 |
Pearl Therapeutics, Inc. |
Methods and systems for conditioning of particulate crystalline materials
|